Author

Brandon M. Carter

Kennedy Krieger InstituteORCID 0000-0001-7705-2878Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Neuroscience· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:mouse· 2 Research Focus:drug response / drug discovery· 1 Assay:electronic health records· 1

Frequent Co-Authors

Brennan J. SullivaniD· 2 shared Pavel A. KipnisiD· 2 shared Shilpa D. KadamiD· 2 shared Li‐Rong ShaoiD· 1 shared

Activity by Year

2019-2021 · peak 1/yr

Co-Author Collaboration Network

4 top collaborators · 6 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersNeuroscience

Brennan J. SullivanORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

NeuroscienceScience SignalingPeer-reviewedNov 9, 2021

Targeting ischemia-induced KCC2 hypofunction rescues refractory neonatal seizures and mitigates epileptogenesis in a mouse model

Brennan J. Sullivan, Pavel A. Kipnis, Brandon M. Carter…·Shilpa D. Kadam

This study shows that enhancing KCC2 function with CLP290 rescues PB-resistant neonatal seizures and reduces epileptogenesis in a mouse model.

29 citations

mouseelectronic health records

NeurosciencebioRxivPreprintDec 23, 2019

TrkB agonists prevent post-ischemic BDNF-TrkB mediated emergence of refractory neonatal seizures in CD-1 pups.

Pavel A. Kipnis, Brennan J. Sullivan, Brandon M. Carter, Shilpa D. Kadam

This study shows that TrkB agonists reduce PB-refractory seizures in neonatal mice by modulating KCC2 stability and TrkB pathway activation post-ischemia.

1 citation

mouseexperimental assay